{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T15:01:31Z","timestamp":1706367691046},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.medcli.2013.06.024","type":"journal-article","created":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T10:31:26Z","timestamp":1378981886000},"page":"423-424","source":"Crossref","is-referenced-by-count":1,"title":["Artralgias y fracturas en un var\u00f3n adulto: m\u00e1s all\u00e1 de la hipovitaminosis D"],"prefix":"10.1016","volume":"142","author":[{"given":"Beatriz","family":"Tejera Segura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melania","family":"Mart\u00ednez-Morillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeronima","family":"Ca\u00f1ellas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Holgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2013.06.024_bib0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/01926230390241990","article-title":"Iron lactate-induced osteomalacia in association with osteoblast dynamics","volume":"31","author":"Matsushima","year":"2003","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.medcli.2013.06.024_bib0010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1507\/endocrj.45.431","article-title":"Saccharated ferric oxide-induced osteomalacia in Japan: Iron-induced osteopathy due to nephropathy","volume":"45","author":"Sato","year":"1998","journal-title":"Endocr J"},{"key":"10.1016\/j.medcli.2013.06.024_bib0055","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.2169\/internalmedicine.51.7450","article-title":"Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide","volume":"51","author":"Yamamoto","year":"2012","journal-title":"Int Med"},{"key":"10.1016\/j.medcli.2013.06.024_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1258\/acb.2008.008151","article-title":"Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia","volume":"46","author":"Shouten","year":"2009","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.medcli.2013.06.024_bib0025","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bone.2009.06.017","article-title":"Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: Another form of FGF23-related hypophosphatemia","volume":"45","author":"Shimizu","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.medcli.2013.06.024_bib0030","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1210\/jc.2008-2396","article-title":"FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: A prospective study","volume":"94","author":"Shouten","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.06.024_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S8756-3282(97)00084-7","article-title":"Saccharated ferric oxide (SFO)-induced osteomalacia: In vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules","volume":"21","author":"Sato","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.medcli.2013.06.024_bib0040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1258\/000456307781646102","article-title":"The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 mesured by three commercial assays","volume":"44","author":"Durham","year":"2007","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.medcli.2013.06.024_bib0045","first-page":"968","article-title":"Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disoidum in women with postmenopausal osteoporosis","volume":"78","author":"Ott","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.06.024_bib0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S8756-3282(02)00869-4","article-title":"Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis","volume":"31","author":"Eriksen","year":"2002","journal-title":"Bone"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775313005010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775313005010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T00:54:36Z","timestamp":1539392076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775313005010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0025775313005010"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2013.06.024","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}